News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.Contact Us
PQMD Welcomes Tanner Pharma Group to Membership
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 firstname.lastname@example.org Annapolis, Md. – January 23, 2019 – The Partnership for Quality Medical Donations (PQMD), is proud to announce the addition of Tanner Pharma Group to their membership. The Charlotte, N.C., based global pharmaceutical company becomes the 42nd member of PQMD. “Tanner Pharma Group is proud…Read More
Tanner Pharma Group to Attend Pharmagora, PQMD, CPhI, US GCSG, and Asembia Conferences
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 email@example.com CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events: Pharmagora | April 7th…Read More
The Max Foundation and Tanner Pharma Partner on Innovative Drug Distribution Model
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 firstname.lastname@example.org Seattle, W.A. – The Max Foundation, an international non-governmental organization dedicated to increasing global access to treatment, care, and support for people living with cancer, and Tanner Pharma Group, a global pharma services company that specializes in patient access to critical medication, have partnered…Read More
Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 email@example.com CHARLOTTE, N.C. – Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of sialorrhea, or chronic drooling, in…Read More